Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Cerebral venous thrombosis and activated protein C resistance

  • 18 Accesses

  • 3 Citations

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Bertina RM, Koeleman BPC, Koster T, et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C (letter). Nature 369:64–67

  2. 2.

    Dahlbäck B, Hildebrand B (1994) Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 91:1396–1400

  3. 3.

    Emmerich J, Poirier O, Evans A, et al (1995) Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance. Lancet 345:321

  4. 4.

    Forsyth PD, Dolan G (1995) Activated protein C resistance in cases of cerebral infarction. Lancet 345:795

  5. 5.

    Majerus PW (1994) Bad bloody by mutation. Nature 369: 14–15

  6. 6.

    Martinelli I, Landi G, Merati G, et al (1996) Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost 75:393–394

  7. 7.

    Rosendaal FR, Koster T, Vandenbroucke JP, et al (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85:1504–1508

  8. 8.

    Trossaert M, Conrad J, Horellou MH, et al (1995) Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations. Presse Med 24:209–212

Download references

Author information

Correspondence to M. Sánchez del Rio.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sánchez del Rio, M., Gómez-Tortosa, E. & Outeriño, J. Cerebral venous thrombosis and activated protein C resistance. J Neurol 243, 727–728 (1996). https://doi.org/10.1007/BF00873981

Download citation

Keywords

  • Public Health
  • Venous Thrombosis
  • Cerebral Venous Thrombosis